This is a preview of subscription content, log in via an institution to check access.
Notes
VigiBase is the WHO's Global Individual Case Safety Report Database.
References
Savage R. Vemurafenib and Atrial fibrillation: Signal strengthening. WHO Pharmaceuticals Newsletter : 17-21, No. 1, 2016. Available from: URL: http://www.who.int/medicines/publications/PharmaNewsletter1_16.pdf
Roche. Response from Roche (re: Vemurafenib and atrial fibrillation: signal strengthening) WHO Pharmaceuticals Newsletter : 21-2, No. 1, 2016. Available from: URL: http://www.who.int/medicines/publications/PharmaNewsletter1_16.pdf
Rights and permissions
About this article
Cite this article
Signal strengthened for vemurafenib-associated AF?. Reactions Weekly 1590, 8 (2016). https://doi.org/10.1007/s40278-016-15060-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15060-4